Acute effect of drinking red and white wines on circulating levels of inflammation-sensitive molecules in men with coronary artery disease

Metabolism: Clinical and Experimental

Volumn 53, Issue 3, 2004, Pages 318-323

  Williams, Michael J A ^a   Sutherland, Wayne H F ^a   Whelan, Alan P ^a   McCormick, Maree P ^a   De Jong, Sylvia A ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; LIPID; POLYPHENOL; VASCULAR CELL ADHESION MOLECULE 1; ALCOHOL; AUTACOID; FLAVONOID; LIPOPROTEIN; PHENOL DERIVATIVE; POLYPHENOLS;

ADULT; AGED; ALCOHOL CONSUMPTION; ANGIOGRAPHY; ARTICLE; BLOOD; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CROSSOVER PROCEDURE; HUMAN; INFLAMMATION; LIPID BLOOD LEVEL; LIVER; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RED WINE; VENOUS BLOOD; WHITE WINE; WINE; BLOOD PRESSURE; CORONARY ARTERY ATHEROSCLEROSIS; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HEART RATE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

AGED; BLOOD GLUCOSE; BLOOD PRESSURE; CORONARY ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; ETHANOL; FLAVONOIDS; HEART RATE; HUMANS; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; PHENOLS; VASCULAR CELL ADHESION MOLECULE-1; WINE;

EID: 1842558691     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2003.10.012     Document Type: Article

References (38)

1. Gaziano JM, Gaziano TA, Glynn RJ, et al: Light-to-moderate alcohol consumption and mortality in the Physicians' Health Study enrollment cohort. J Am Coll Cardiol 35:96-105, 2000
2. Fuchs CS, Stampfer MJ, Colditz GA, et al: Alcohol consumption and mortality among women. N Engl J Med 332:1245-1250, 1995
3. Gronbach M, Deis A, Sorensen TI, et al: Mortality associated with moderate intakes of wine, beer, or spirits. BMJ 310:1165-1169, 1995
4. Klatsky AL, Armstrong MA, Friedman GD: Relations of alcoholic beverage use to subsequent coronary artery disease hospitalization. Am J Cardiol 58:710-714, 1986
5. Renaud S, De Lorgeril M: Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet 339:1523-1526, 1992
6. Truelson T, Gronbach M, Schnohr P, et al: Intake of beer, wine, and spirits and risk of stroke: The Copenhagen Heart Study. Stroke 29:2467-2472, 1998
7. Nigdikar SV, Williams NR, Griffin BA, et al: Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. Am J Clin Nutr 68:258-265, 1998
8. Blanco-Colio LM, Valderama M, Alvarez-Sala LA, et al: Red wine intake prevents nuclear factor-κβ activation in peripheral blood mononuclear cells of healthy volunteers during postprandial lipemia. Circulation 102:1020-1026, 2000
9. Agewall S, Wright S, Doughty RN, et al: Does a glass of red wine improve endothelial function? Eur Heart J 21:74-78, 2000
10. Stein JH, Keevil JG, Wiebe DA, et al: Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 100:1050-1055, 1999
11. Barnes PJ, Karin M: Nuclear factor-κβ: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071, 1997
12. Bertelli AAE, Baccalini R, Battaglia E, et al: Resveratrol inhibits TNF alpha-induced endothelial cell activation. Therapie 56:613-616, 2001
13. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 105:1135-1143, 2002
14. Yudkin JS, Kumari M, Humphries SE, et al: Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis 148:209-214, 2000
15. Rifai N, Joubran R, Yu H, et al: Inflammatory markers in men with angiographically documented coronary heart disease. Clin Chem 45:1967-1973, 1999
16. Schumacher A, Seljeflot I, Sommervoll L, et al: Increased levels of markers of vascular inflammation in patients with coronary heart disease. Scand J Clin Lab Invest 62:59-68, 2002
17. Whelan AP, Sutherland WHF, McCormick MP, et al: The effects of white and red wine on endothelial function in subjects with coronary artery disease. Intern Med J (in press)
18. Duthie GG, Pedersen MW, Gardner PT, et al: The effect of whisky and wine consumption on total phenol content and antioxidant capacity of plasma from healthy volunteers. Eur J Clin Nutr 52:733-736, 1998
19. Singleton VL, Orthofer R, Lamuela-Raventós RM: Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin-Ciocalteu reagent. Methods Enzymol 299:152-178, 1999
20. 2+ precipitation procedure for quantification of high-density lipoprotein cholesterol. Clin Chem 28:1379-1388, 1982
21. Colantoni A, Duffner LA, De Maria N, et al: Dose-dependent effect of ethanol on hepatic oxidative stress and interleukin-6 production after burn injury in the mouse. Alcohol Clin Exp Res 24:1443-1448, 2000
22. Reinke LA: Spin trapping evidence for alcohol-associated oxidative stress. Free Radic Biol Med 32:953-957, 2002
23. L proteins. Oncogene 21:32-43, 2002
24. Fong Y, Marano MA, Moldawer LL, et al: The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans. J Clin Invest 85:1896-1904, 1990
25. Liao J, Keiser JA, Scales WE, et al. Role of corticosterone in TNF and IL-6 production in isolated perfused rat liver. Am J Physiol 268:R699-706, 1995
26. Hingorani AD, Cross J, Kharbanda RK, et al: Acute systemic inflammation impairs endothelium-dependent dilation in humans. Circulation 102:949-999, 2000
27. Bhagat K, Hingorani AD, Palacios M, et al: Cytokine-induced venodilation in humans in vivo: eNOS masquerading as iNOS. Cardiovasc Res 41:754-764, 1999
28. Dichtl W, Nilsson L, Goncalves I, et al: Very low-density lipoprotein activates nuclear factor-κB in endothelial cells. Circ Res 84:1085-1094, 1999
29. Vgontas AN, Papanicolaou DA, Bixler EO, et al: Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab 84:2603-2607, 1999
30. Ceriello A, Bortolotti N, Motz E, et al: Red wine protects diabetic patients from meal-induced oxidative stress and thrombosis activation: A pleasant approach to the prevention of cardiovascular disease in diabetes. Eur J Clin Nutr 31:322-328, 2001
31. Avogaro A, Duner E, Marescotti C, et al: Metabolic effects of moderate alcohol intake with meals in insulin-dependent diabetics controlled by artificial endocrine pancreas (AEP) and in normal subjects. Metabolism 32:463-470, 1983
32. Stott DJ, Dutton M, Murray GD, et al: Hemodynamic effects of a single moderate dose of alcohol in elderly subjects. J Stud Alcohol 52:377-379, 1991
33. Schieffer B, Schieffer E, Hilfiker-Kleiner D, et al: Expression of angiotensin II and interleukin-6 in human coronary atherosclerotic plaques: Potential implications for inflammation and plaque instability. Circulation 101:1372-1378, 2000
34. Solís-Heruzzo JA, Rippe RA, Schrum LW, et al: Interleukin-6 increases rat metalloproteinase-13 gene expression through stimulation of activator protein 1 transcription factor in cultured fibroblasts. J Biol Chem 274:30919-30926, 2003
35. Franchimont N, Rydziel S, Delany AM, et al: Interleukin-6 and its soluble receptor cause a marked induction of collagenase 3 expression in rat osteoblast cultures. J Biol Chem 272:12144-12150, 1997
36. Papanicolaou DA: The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 128:127-137, 1998
37. Xing Z, Gauldie J, Cox G, et al: IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 101:311-320, 1998
38. Pedersen BK, Steensberg A, Schjerling P: Muscle-derived interleukin-6: Possible biological effects. J Physiol 536:329-337, 2001